GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · IEX Real-Time Price · USD
27.76
-0.93 (-3.24%)
At close: Jul 2, 2024, 4:00 PM
28.37
+0.61 (2.20%)
After-hours: Jul 2, 2024, 7:44 PM EDT

GeneDx Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current20232022202120202019
Market Capitalization
726711021,076611-
Market Cap Growth
-18.36%-30.24%-90.52%76.11%--
Enterprise Value
7316050686535-90
PE Ratio
--0.40-0.19-4.38-2.53-
PS Ratio
3.270.350.445.073.41-
PB Ratio
3.500.310.402.77-1.85-
P/FCF Ratio
-1.67-0.39-0.31-5.09-4.88-
P/OCF Ratio
-1.69-0.40-0.32-5.65-6.56-
EV/Sales Ratio
3.300.300.223.242.99-0.46
EV/EBITDA Ratio
-2.33-0.42-0.09-3.13-2.383.97
EV/EBIT Ratio
-1.81-0.34-0.08-2.83-2.243.11
EV/FCF Ratio
-1.71-0.33-0.15-3.25-4.282.63
Debt / Equity Ratio
0.570.520.290.03-0.13-0.28
Debt / EBITDA Ratio
-1.13-0.83-0.13-0.05-0.19-1.10
Debt / FCF Ratio
-0.83-0.66-0.22-0.05-0.35-0.73
Quick Ratio
2.802.771.164.222.063.40
Current Ratio
3.223.101.474.772.374.08
Asset Turnover
0.520.440.340.550.79-
Interest Coverage
-117.36--896.95-85.56-96.55-36.94
Return on Equity (ROE)
-54.80%-63.50%-123.20%320.10%115.30%-
Return on Assets (ROA)
-31.60%-37.80%-79.30%-63.20%-106.00%-
Return on Capital (ROIC)
-41.23%-52.00%-204.75%-111.79%84.38%47.73%
Earnings Yield
-18.60%-246.93%-538.02%-22.81%-39.50%-
FCF Yield
-19.65%-255.44%-326.82%-19.63%-20.48%-
Buyback Yield / Dilution
-29.91%-137.49%-212.57%-2112850.97%-3775.00%99.99%
Total Shareholder Return
-29.91%-137.49%-212.57%-2112850.97%-3775.00%99.99%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).